Oncolytics Biotech, Inc.
(Toronto Stock Exchange : ONCY)

( )
ONCY After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -4.54%69.361.0%$1525.38m
BIIBBiogen, Inc. -0.55%308.391.5%$649.29m
REGNRegeneron Pharmaceuticals, Inc. 3.00%444.572.6%$562.57m
AMGNAmgen, Inc. -1.85%199.731.3%$547.94m
ILMNIllumina, Inc. 2.21%265.673.5%$420.99m
MRNAModerna, Inc. -0.88%25.930.0%$398.69m
VRTXVertex Pharmaceuticals, Inc. 0.33%224.031.9%$365.54m
ALXNAlexion Pharmaceuticals, Inc. 2.11%94.032.0%$231.60m
CODXCo-Diagnostics, Inc. -17.11%13.230.0%$212.36m
AAgilent Technologies, Inc. -0.59%76.971.6%$178.33m
EXASEXACT Sciences Corp. 0.16%80.9524.0%$171.40m
BMRNBioMarin Pharmaceutical, Inc. 0.61%90.374.3%$120.49m
SGENSeattle Genetics, Inc. 5.12%113.866.1%$114.83m
INCYIncyte Corp. -0.57%75.412.5%$113.73m
NVAXNovavax, Inc. 35.59%16.00184.0%$112.44m

Company Profile

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.